Codrituzumab, CAS [[1365267-33-9]]

Produktübersicht

• Artikelname: Codrituzumab, CAS [[1365267-33-9]]
• Artikelnummer: MCE-HY-P99013
• Hersteller Artikelnummer: HY-P99013
• Alternativnummer: MCE-HY-P99013-25MG,MCE-HY-P99013-100MG,MCE-HY-P99013-50MG,MCE-HY-P99013-1MG,MCE-HY-P99013-5MG,MCE-HY-P99013-10MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: GC33, RO5137382

Produktbeschreibung

Codrituzumab (GC33) is a humanized monoclonal antibody targeting human GPC3 (glypican-3), with high affinity (Kd of 0.673 nM). GPC3 is an oncofetal protein expressed on the cell surface of hepatocellular carcinoma (HCC). Codrituzumab induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth[1][2][3][4].

Produkteigenschaften

• Molekulargewicht: (145.58 kDa)
• Reinheit: 99.07
• CAS Nummer: [1365267-33-9]
• Target-Kategorie: Glycoprotein VI

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies